The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to ...
AstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker said Wednesday. The shot ...
The vaccine, initially approved in January 2021, faced safety concerns over rare blood clots, prompting various countries to halt its use temporarily.
In an update on the European Medicines Agency's website Wednesday ... But studies later suggested that the pricier messenger ...
Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday ...
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
Covid-19 is an infectious disease caused by a newly discovered coronavirus. Most people infected will experience mild to moderate respiratory illness and recover without requiring special treatment.
GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents related to messenger RNA (mRNA) technology in their COVID-19 ...
GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the Comirnaty partners. In a lawsuit filed in federal ...
Brazilian scientists conducted the first research project to evaluate the immunity induced in an actual group of vaccinated ...